Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice

被引:25
作者
Hsieh, Ao-Ho [2 ]
Jhou, Yi-Jyun [3 ]
Liang, Chung-Ting [4 ]
Chang, Mingi [1 ]
Wang, Shih-Lien [3 ]
机构
[1] Dev Ctr Biotechnol, New Taipei City 221, Taiwan
[2] Tzu Chi Univ, Inst Med Sci, Hualien 970, Hualien County, Taiwan
[3] Tzu Chi Univ, Inst Microbiol Immunol & Biochem, Hualien 970, Hualien County, Taiwan
[4] NLAC, Taipei 115, Taiwan
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; SMALL NUCLEAR RIBONUCLEOPROTEIN; EPSTEIN-BARR-VIRUS; MATRIX PROTEIN; ANTI-DSDNA; IMMUNOGLOBULIN DEPOSITION; MOLECULAR MIMICRY; IMMUNE-RESPONSE; DNA ANTIBODIES; INFECTION;
D O I
10.1186/ar3481
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Human cytomegalovirus (HCMV) infection has been implicated in the development of autoimmunity, including systemic lupus erythematosus (SLE). Previously we reported that HCMV phosphoprotein 65 (pp65) could induce early onset of autoantibody and glomerulonephritis on lupus-prone NZB/W mice. This study further examined whether the B cell epitope(s) in pp65 is able to drive the development of autoantibody. Methods: Sera from SLE patients or HCMVpp65-immunized mice were analyzed for anti-nuclear antibody by immunoblotting, enzyme-linked immunosorbent assay (ELISA), immunofluorescent stain and Crithidia luciliae stain. The deposition of immunoglobulin to the kidney was also examined by immunofluorescent stain. The interactions between pp65 sub-fragment to cellular proteins were revealed by yeast two-hybrid analyses. Results: Our results showed that most SLE patients possessed antibodies to the C-terminal half of the HCMVpp65 antigen. Of these positive sera, 73% were also positive to the pp65336-439 sub-fragment. The immunization of pp65336-439 induced formation of multiple anti-nuclear antibodies, including anti-chromatin, anti-centriole, antimitotic spindle type I/II (MSA I/II) and a significant elevation of anti-double-stranded DNA (anti-dsDNA) antibodies on BALB/c mice. Yeast two-hybrid analyses revealed the binding of pp65336-439 sub-fragment to cellular proteins. Immunoglobulin deposition on glomeruli was also detected on pp65336-439-immunized mice. Conclusions: Our data suggested that HCMVpp65336-439 sub-fragment may induce cross-reactive antibodies to several nuclear antigens, which could contribute to the development of autoimmunity in genetic-suspected individuals.
引用
收藏
页数:15
相关论文
共 41 条
[1]  
Andreassen K, 1999, EUR J IMMUNOL, V29, P2715, DOI 10.1002/(SICI)1521-4141(199909)29:09<2715::AID-IMMU2715>3.0.CO
[2]  
2-#
[3]   Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus [J].
Arbuckle, MR ;
James, JA ;
Kohlhase, KF ;
Rubertone, MV ;
Dennis, GJ ;
Harley, JB .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) :211-219
[4]   Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[5]   IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus [J].
Bijl, M ;
Dijstelbloem, HM ;
Oost, WW ;
Bootsma, H ;
Derksen, RHWM ;
Aten, J ;
Limburg, PC ;
Kallenberg, CGM .
RHEUMATOLOGY, 2002, 41 (01) :62-67
[6]   Human cytomegalovirus pp65 lower matrix protein:: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice [J].
Chang, M ;
Pan, MR ;
Chen, DY ;
Lan, JL .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (01) :167-179
[7]   Induction of antiphospholipid autoantibody during cytomegalovirus infection [J].
Cheng, HM ;
Khairullah, NS .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (06) :1493-1494
[8]   Visualization of the dynamic multimerization of human Cytomegalovirus pp65 in punctuate nuclear foci [J].
Cui, Zongqiang ;
Zhang, Ke ;
Zhang, Zhiping ;
Liu, Yalan ;
Zhou, Yafeng ;
Wei, Hongping ;
Zhang, Xian-En .
VIROLOGY, 2009, 392 (02) :169-177
[9]  
Curtis HAE, 1999, EUR J IMMUNOL, V29, P3643, DOI 10.1002/(SICI)1521-4141(199911)29:11<3643::AID-IMMU3643>3.0.CO
[10]  
2-J